Advertisement

Predicting cervical intraepithelial neoplasia recurrence in HIV-infected and -noninfected women by detecting aberrant promoter methylation in the CDH1, TIMP3, and MGMT genes

  • Claudia Teixeira da Costa Lodi
  • Márcia Antoniazi Michelin
  • Maria Inês Miranda Lima
  • Eddie Fernando Candido Murta
  • Letícia da Conceição Braga
  • Leticia Montes
  • Victor Hugo Melo
Gynecologic Oncology
  • 9 Downloads

Abstract

Purpose

Aberrant DNA methylation is present in virtually all types of human cancer. There is no clear evidence that methylation status can predict bad prognosis in patients with CIN recurrence in HIV infected. This study evaluates the relationship between aberrant methylation of CpG islands of CDH1, TIMP3 and MGMT genes and CIN recurrence in HIV-infected and -noninfected women.

Methods

This is a nested case–control study involving 33 cases with CIN recurrence and 114 controls without recurrence, HIV infected and noninfected, treated with LEEP, between 1999 and 2004. Recurrence diagnosis was established after biopsy. Genes methylation profile was assessed by MSP-PCR technique in formalin-fixed, paraffin-embedded cone specimens. Statistical analysis was performed to compare categorical variables, using χ2 test with Yates correction and Fisher’s exact test. Multivariate analysis was carried out using logistic regression.

Results

CIN recurrence was more frequent in women with glandular involvement (OR 11.6; 95% CI 2.93–45.89) and compromised surgical margins (OR 2.5; 95% CI 0.87–7.27) in the cervical cone and in HIV-infected women (OR 2.47; 95% CI 0.87–7.05). One methylated allele of CDH1, TIMP3 and MGMT genes was present in 87.9% women with CIN recurrence. Promoter hypermethylation of TIMP3 and MGMT was detected in women with CIN recurrence and without CIN recurrence independent of HIV infection with significant difference between groups (p = 0.04 and p = 0.02, respectively).

Conclusions

CIN recurrence was associated with glandular involvement and compromised margins in cone biopsy and HIV infection. The presence of CpG islands hemimethylation in TIMP3 and MGMT genes is a promising triage method in CIN recurrence.

Keywords

DNA methylation Human immunodeficiency virus Cervical intraepithelial neoplasia Recurrence Loop electrosurgical excision procedure Human papillomavirus 

Notes

Acknowledgements

We thank FAPEMIG for the financial support in this study.

Author contribution

CTCL: Project development, data collection, data analysis, manuscript writing.MAM: Project development. MIML: Data collection. EFCM: Project development. LCB: data analysis, manuscript writing. LM: Project development.

VHM-Project development, Data Collection, Data analysis, Manuscript writing.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

All procedures performed in studies in volving human participants were in accordance with the ethical standards of the institutional and/or national research committee and withthe 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Vasiljević N, Scibior-Bentkowska D, Brentnall A, Cuzick J, Lorincz A (2014) A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers. J Clin Virol 59(3):161–166CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Lima MI, Tafuri A, Araújo AC, de Miranda Lima L, Melo VH (2009) Cervical intraepithelial neoplasia recurrence after conization in HIV-positive and HIV-negative women. Int J Gynaecol Obstet 104(2):100–104CrossRefPubMedGoogle Scholar
  3. 3.
    Lodi CT, Michelin MA, Lima MI, Teixeira NC, Adad SJ, Murta EF et al (2011) Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women. Arch Gynecol Obstet 284(1):191–197CrossRefPubMedGoogle Scholar
  4. 4.
    Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF (2001) Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 7(3):584–589PubMedGoogle Scholar
  5. 5.
    Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A et al (2004) Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 10(10):3396–3400CrossRefPubMedGoogle Scholar
  6. 6.
    Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J et al (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2:24CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Luhn P, Walker J, Schiffman M, Zuna RE, Dunn ST, Gold MA et al (2013) The role of co-factors in the progression from human papillomavirus infection to cervical cancer. Gynecol Oncol 128(2):265–270CrossRefPubMedGoogle Scholar
  8. 8.
    Bae JH, Kim CJ, Park TC, Namkoong SE, Park JS (2007) Persistence of human papillomavirus as a predictor for treatment failure after loop electrosurgical excision procedure. Int J Gynecol Cancer 17(6):1271–1277CrossRefPubMedGoogle Scholar
  9. 9.
    Serati M, Siesto G, Carollo S, Formenti G, Riva C, Cromi A et al (2012) Risk factors for cervical intraepithelial neoplasia recurrence after conization: a 10-year study. Eur J Obstet Gynecol Reprod Biol 165(1):86–90CrossRefPubMedGoogle Scholar
  10. 10.
    Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T et al (2013) Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis 17(5 0 1):S78–S84CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Russomano F, Paz BR, Camargo MJ, Grinstejn BG, Friedman RK, Tristao MA et al (2013) Recurrence of cervical intraepithelial neoplasia in human immunodeficiency virus-infected women treated by means of electrosurgical excision of the transformation zone (LLETZ) in Rio de Janeiro. Braz Sao Paulo Med J 131(6):405–410Google Scholar
  12. 12.
    Del Mistro A, Matteucci M, Insacco EA, Onnis G, Da Re F, Baboci L et al (2015) Long-term clinical outcome after treatment for high-grade cervical lesions: a retrospective monoinstitutional cohort study. Biomed Res Int 2015:984528PubMedPubMedCentralGoogle Scholar
  13. 13.
    Herfs M, Somja J, Howitt BE, Suarez-Carmona M, Kustermans G, Hubert P et al (2015) Unique recurrence patterns of cervical intraepithelial neoplasia after excision of the squamocolumnar junction. Int J Cancer 136(5):1043–1052CrossRefPubMedGoogle Scholar
  14. 14.
    Baloglu A, Uysal D, Bezircioglu I, Bicer M, Inci A (2010) Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions. Arch Gynecol Obstet 282(1):69–73CrossRefPubMedGoogle Scholar
  15. 15.
    Cejtin HE, Malapati R, Chaparala S (2011) A comparison of loop electrosurgical excision procedures between human immunodeficiency virus-seropositive and -seronegative women. J Low Genit Tract Dis 15(1):37–41CrossRefPubMedGoogle Scholar
  16. 16.
    Kodampur M, Kopeika J, Mehra G, Pepera T, Menon P (2013) Endocervical crypt involvement by high-grade cervical intraepithelial neoplasia after large loop excision of transformation zone: do we need a different follow-up strategy? J Obstet Gynaecol Res 39(1):280–286CrossRefPubMedGoogle Scholar
  17. 17.
    Du R, Meng W, Chen ZF, Zhang Y, Chen SY, Ding Y (2013) Post-treatment human papillomavirus status and recurrence rates in patients treated with loop electrosurgical excision procedure conization for cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 34(6):548–551PubMedGoogle Scholar
  18. 18.
    Huchko MJ, Leslie H, Maloba M, Bukusi EA, Cohen CR (2014) Factors associated with recurrence of cervical intraepithelial neoplasia 2 + after treatment among HIV-infected women in Western Kenya. J Acquir Immune Defic Syndr 66(2):188–192PubMedPubMedCentralGoogle Scholar
  19. 19.
    Huchko MJ, Leslie H, Maloba M, Zakaras J, Bukusi E, Cohen CR (2015) Outcomes up to 12 Months after Treatment With Loop Electrosurgical Excision Procedure for Cervical Intraepithelial Neoplasia Among HIV-Infected Women. J Acquir Immune Defic Syndr 69(2):200–205CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Brentnall AR, Vasiljević N, Scibior-Bentkowska D, Cadman L, Austin J, Szarewski A et al (2014) A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes. Int J Cancer 135(6):1425–1432CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Lorincz AT (2014) Cancer diagnostic classifiers based on quantitative DNA methylation. Expert Rev Mol Diagn 14(3):293–305CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Vidal AC, Henry NM, Murphy SK, Oneko O, Nye M, Bartlett JA et al (2014) PEG1/MEST and IGF2 DNA methylation in CIN and in cervical cancer. Clin Transl Oncol 16(3):266–272CrossRefPubMedGoogle Scholar
  23. 23.
    Wentzensen N, Sherman ME, Schiffman M, Wang SS (2009) Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science. Gynecol Oncol 112(2):293–299CrossRefGoogle Scholar
  24. 24.
    Szalmás A, Kónya J (2009) Epigenetic alterations in cervical carcinogenesis. Semin Cancer Biol 19(3):144–152CrossRefPubMedGoogle Scholar
  25. 25.
    De Vuyst H, Franceschi S, Plummer M, Mugo NR, Sakr SR, Meijer CJ et al (2015) Methylation levels of CADM1, MAL, and MIR124-2 in cervical scrapes for triage of HIV-infected, high-risk HPV-positive women in Kenya. J Acquir Immune Defic Syndr 70(3):311–318CrossRefPubMedGoogle Scholar
  26. 26.
    Walker P, Dexeus S, de Palo G, Barrasso R, Campion M, Girardi F et al. (2009) International terminology of colposcopy: an updated report from the international federation for cervical pathology and colposcopy. Available http://www.ifcpc.org/ifcpc/terminology. Accessed 12 Sept 2009
  27. 27.
    Smith JH (2002) Bethesda 2001. Cytopathology 13(1):4–10CrossRefPubMedGoogle Scholar
  28. 28.
    Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB (1996) Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93(18):9821–9826CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Heard I, Potard V, Foulot H, Chapron C, Costagliola D, Kazatchkine MD (2005) High rate of recurrence of cervical intraepithelial neoplasia after surgery in HIV-positive women. J Acquir Immune Defic Syndr 39(4):412–418CrossRefPubMedGoogle Scholar
  30. 30.
    Nappi L, Carriero C, Bettocchi S, Herrero J, Vimercati A, Putignano G (2005) Cervical squamous intraepithelial lesions of low-grade in HIV-infected women: recurrence, persistence, and progression, in treated and untreated women. Eur J Obstet Gynecol Reprod Biol 121(2):226–232CrossRefPubMedGoogle Scholar
  31. 31.
    Malapati R, Chaparala S, Cejtin HE (2011) Factors influencing persistence or recurrence of cervical intraepithelial neoplasia after loop electrosurgical excision procedure. J Low Genit Tract Dis 15(3):177–179CrossRefPubMedGoogle Scholar
  32. 32.
    Terra AP, Murta EF, Maluf PJ, Caballero OL, Brait M, Adad SJ (2007) Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III. Tumori 93(6):572–579CrossRefPubMedGoogle Scholar
  33. 33.
    Kong TW, Son JH, Chang SJ, Paek J, Lee Y, Ryu HS (2014) Value of endocervical margin and high-risk human papillomavirus status after conization for high-grade cervical intraepithelial neoplasia, adenocarcinoma in situ, and microinvasive carcinoma of the uterine cervix. Gynecol Oncol 135(3):468–473CrossRefPubMedGoogle Scholar
  34. 34.
    Ryu A, Nam K, Kwak J, Kim J, Jeon S (2012) Early human papillomavirus testing predicts residual/recurrent disease after LEEP. J Gynecol Oncol 23(4):217–225CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Fu Y, Chen C, Feng S, Cheng X, Wang X, Xie X et al (2015) Residual disease and risk factors in patients with high-grade cervical intraepithelial neoplasia and positive margins after initial conization. Ther Clin Risk Manag 11:851–856CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Manchanda R, Baldwin P, Crawford R, Vowler SL, Moseley R, Latimer J et al (2008) Effect of margin status on cervical intraepithelial neoplasia recurrence following LLETZ in women over 50 years. BJOG 115(10):1238–1242CrossRefPubMedGoogle Scholar
  37. 37.
    Jin J, Li L, Zhang F (2015) Meta-analysis of high risk factors of residue or relapse of cervical intraepithelial neoplasia after conization. J Biol Regul Homeost Agents 29(2):451–458PubMedGoogle Scholar
  38. 38.
    van Bogaert LJ (2015) Involved LEEP excision margins as predictor of residual/recurrent disease in HIV-positive and HIV-negative women in a low-resource setting. Anal Quant Cytopathol Histpathol 37(2):105–108PubMedGoogle Scholar
  39. 39.
    Wu J, Jia Y, Luo M, Duan Z (2016) Analysis of residual/recurrent disease and its risk factors after loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia. Gynecol Obstet Invest 81(4):296–301CrossRefPubMedGoogle Scholar
  40. 40.
    Thomison J, Thomas LK, Shroyer KR (2008) Human papillomavirus: molecular and cytologic/histologic aspects related to cervical intraepithelial neoplasia and carcinoma. Hum Pathol 39(2):154–166CrossRefPubMedGoogle Scholar
  41. 41.
    Petrova YI, Schecterson L, Gumbiner BM (2016) Roles for E-cadherin cell surface regulation in cancer. Mol Biol Cell 27(21):3233–3244CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Banzai C, Nishino K, Quan J, Yoshihara K, Sekine M, Yahata T et al (2014) Promoter methylation of DAPK1, FHIT, MGMT, and CDKN2A genes in cervical carcinoma. Int J Clin Oncol 19(1):127–132CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Claudia Teixeira da Costa Lodi
    • 1
  • Márcia Antoniazi Michelin
    • 2
  • Maria Inês Miranda Lima
    • 3
  • Eddie Fernando Candido Murta
    • 2
  • Letícia da Conceição Braga
    • 4
  • Leticia Montes
    • 5
  • Victor Hugo Melo
    • 6
  1. 1.Medical Science School of Minas GeraisBelo HorizonteBrazil
  2. 2.Research Institute of OncologyFederal University of Triangulo MineiroUberabaBrazil
  3. 3.Gynecologist at Santa Casa Belo HorizonteBelo HorizonteBrazil
  4. 4.Cell Biology Laboratory of Research and Development Management of Ezequiel Dias FoundationBelo HorizonteBrazil
  5. 5.Biomedical of Research Institute of OncologyFederal University of Triangulo MineiroUberabaBrazil
  6. 6.School of MedicineFederal University of Minas GeraisBelo HorizonteBrazil

Personalised recommendations